Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn InfantsColeen K. Cunningham, Karin Nielsen‐Saines, Lynne Mofenson et al.|The Journal of Infectious Diseases|2019Cited by 62
Maternal HIV infection and the milk microbiomeNicole H. Tobin, Fan Li, Sean S. Brummel et al.|Microbiome|2024Cited by 8
Metabolomic profiling of preterm birth in pregnant women living with HIVNicole H. Tobin, Aisling Murphy, Fan Li et al.|Metabolomics|2023Cited by 4
Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Week 24 Results From IMPAACT 2014Ann J. Melvin, Ka Lai Yee, Kathryn P. Gray et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2022Cited by 3